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Summary This review searched previous works of apoptosis induction in human oral squamous
cell carcinoma (OSCC) cells. Many chemotherapeutic drugs, natural products,metabolic inhibitors,
hormone receptor ligands and gene manipulations induced the apoptosis directly or indirectly by
reverting the anti-apoptotic pathways. However, these antitumor agents, sometimes induced
incomplete apoptosis or other types of cell death characterized by lack of caspase activation
and internucleosomal DNA fragmentation, depending on the target cells or the chemical structure
of inducers. There were very few investigations that have compared the cytotoxicity of these
antitumor substances against OSCC cells with that of normal oral cells. Furthermore, their
apoptosis-inducing activity has not been correlatedwell with tumor-specificity (higher cytotoxicity
against tumor cells versus normal cells). These accumulated evidences provide the cautionary note
against the apoptosis-oriented research.
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174 H. Sakagami1. Introduction
Squamous cell carcinoma (SCC) is a form of cancer of the
carcinoma type that may occur in many different organs,
including the skin, lips, mouth, esophagus, urinary bladder,
prostate, lungs, vagina, and cervix. It is a malignant tumor of
squamous epithelium, and invasive cancers are able to
spread to other organs and cause metastasis. Most cases of
head and neck cancer are due to SCC, and caused by tobacco
and alcohol, and human papilloma virus. Oral cancer is one of
the most disfiguring types of cancer, since the surgical
removal of the tumor may result in facial distortion.
Oral squamous cell carcinoma (OSCC) is the fifth most
common cancer worldwide, with the number of cases con-
sistently increasing in developing countries. Despite focused
efforts to improve therapy, 5-year survival rates for persons
with advanced-stage OSCC remain discouragingly low. OSCC,
like other types of cancer, is a genetic disease, resulting in
the loss of differentiation, and possibly generated by the
decline of apoptotic potential and immunity [1]. Aggressive
OSCC with a high score of malignancy showed reduced
expression of the tumor suppressor gene phosphatase and
tensin (PTEN) homologue deleted on chromosome 10 [2], p53
positivity and low apoptotic index [3], and increased expres-
sion of anti-apoptotic proteins such as survivin [4] and Bcl-2
[5]. Down-regulation of heat shock protein 27 enhanced the
transformation of oral epithelial dysplasia into OSCC, possi-
bly by impairing the protective mechanism against mutagen-
esis induced by environmental factors [6]. Carcinogenesis of
OSCC is related to the overexpression of prolyl isomerase Pin
1 [7], a stronghold for the therapy of Alzheimer’s disease.
These data suggest that OSCC may be produced by an imbal-
ance of the regulation between cell survival and apoptosis.
Early detection combined with strategies for local inter-
vention, such as chemoprevention prior to SCC development,could dramatically improve clinical outcomes. Microarray
analysis of small noncoding microRNAs (miRNAs) in the
patient can be a useful prognostic markers [8].
Recently, the targeted elimination of OSCC cells by indu-
cing apoptosis has emerged as a valued strategy to combat
oral cancer. Studies utilizing a variety of chemical or biolo-
gical interventions demonstrated promising results for induc-
tion of apoptosis in oral malignant cells [9]. There are at least
three types of cell death: apoptosis, autophagy and necrosis
[10,11]. The present review surveys recent studies of the
type of cell death (either apoptosis or non-apoptosis) induced
by various antitumor agents in OSCC and the relationship to
their tumor-specificity.
2. Classification of three major types of cell
death
2.1. Apoptosis
Apoptosis is characterized by morphological changes such as
cell shrinkage, pyknosis, densed cytoplasm, tightly packed
organelles, chromatin condensation, and loss of cell surface
microvilli [12]. Markers of apoptosis include DNA fragmenta-
tion (assessed by TUNEL method on fixed cell slide prepara-
tions, proportion of sub-G1 cells on FACS analysis, ladder
pattern on agarose gel electrophoresis), decline of mitochon-
drial membrane potential, cytochrome c release from mito-
chondria, activation of caspase-3 using specific synthetic
substrate or poly(ADP-ribose)polymerase (PARP).
2.2. Autophagy
Autophagic cell death is characterized by the sequestration
of cytoplasm and organelles in double or multimembrane
vesicles and delivery to the cell’s own lysosomes for subse-
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on both continuous protein synthesis and the continuous
presence of ATP [14]. Markers of autophagy is formation
of phagophore and autophagosome detected by electron
microscopy, Atg8/LC3 western blotting and ubiquitin-like
protein conjugation systems (increase in the amount of
LC3-II, and Atg12—Atg5 conjugation) or fluorescent micro-
scopy (increase in punctuate LC3 (or Atg18), TOR and Atg1
kinase activity) [11].
2.3. Necrosis
Necrosis is an uncontrolled and passive process that usually
affects large fields of cells. Necrotic cell injury is mediated by
two main mechanisms, interference with the energy supply
of the cell and direct damage to cell membranes [10].
Necrosis is characterized by cell swelling, formation of cyto-
plasmic vacuoles, distended endoplasmic reticulum, forma-
tion of cytoplasmic blebs, condensed swollen or ruptured
mitochondria, disaggregation and detachment of ribosomes,
disrupted organelle membranes, swollen and ruptured lyso-
somes and eventually disruption of the cell membrane [15].
3. Apoptosis inducers
3.1. Apoptosis inducers against OSCC (Table 1)
3.1.1. Chemotherapeutic drugs
Chemotherapeutic drugs are the most frequently used apop-
tosis inducers ofOSCC. 5-FU, peplomycin, cisplatin (CDDP) and
g-ray,NOgenerator (ONOO, SIN-1 andSNP) inducedapoptosis
inOSCC cells (OSC-4) [16]. These treatments slightly increased
the intracellular concentration of NO and O2
 levels, and
induced the nitration of cytochrome c and caspase-3. CDDP
induced the rapiddecline of surviving geneexpression [17] and
augmentation of apoptosome molecules (cytochrome c and
Apaf-1) and activation of caspase-9 and capase-3, but no
change in NF-kB nor the expression of anti-apoptotic proteins
(TRAF-1, TRAF-2, c-FLIP). This suggests that cisplatin exerts its
apoptotic action by the mitochondria-mediated activation of
caspases but not by the activation of caspases due to the
inhibition of NF-kB activity that follows the suppression of
anti-apoptotic proteins [18]. Low-dose of CDDP enhanced the
Fas/CD95) expression and increased susceptibility to apoptosis
in oral cancer cell line (UT-SCC-20A) [19].
Carboplatin (CBDCA) induced apoptosis in human well-
differentiated tongue squamous carcinoma cell lines (SCC-9
and SCC-25). The carboplatin-induced apoptosis was oblit-
erated by neutralizing anti-Fas (APO-1/CD95) and anti-Fas
ligand (FasL). Anti-Fas antibody itself was inactive, but in the
presence of carboplatin, markedly enhanced the apoptosis.
There was large enhancement of FADD expression, but no
alterations in Fas or FasL expression upon carboplatin treat-
ment. Suppression of FADD expression using the specific
antisense oligonucleotide resulted in a failure of carboplatin
induction of cell death. These data suggest that carboplatin
may switch nonfunctional Fas to functional Fas by up-regula-
tion of FADD expression, resulting in activation of Fas-sensi-
tive pathway leading to apoptosis [20]. Carboplatin induced
apoptosis in OSCC (MIT7) probably through the cleavage of
Bax-alpha and Bcl-x(L) [21].Paclitaxel, an antimitotic chemotherapeutic agent,
induced apoptosis in human OSCC cell line (NB-1) by down-
regulation of Bcl-2 and up-regulation of Bax [22]. Docetaxel
induced Bax expression at both protein and mRNA levels in
not all OSCC cell lines and clinical cases, but the enhanced
expression of Bax has been suggested to be contributed to the
antitumor effects of chemotherapy [23].
Peplomycin and bleomycin induced apoptosis in OSCC
(SSKCN) [24]. Pingyangmycin (bleomycin A) induced growth
arrest at G2-M phase of the cell cycle and apoptosis in OSCC
(KB cells) [25].
137Cs irradiation, 5-fluorouracil (5-FU) or CDDP enhanced
the apoptosis of OSCC induced by interleukin-2-activated
lymphocytes [26]. Low-dose (0.5-Gy) of radiation caused
enhanced apoptosis in human OSCC cells (T-167, T-409) with-
out induction of transmembrane protein P-glycoprotein
(MDR1), while higher dose (2-Gy) of radiation increased
expression of MDR1 by NF-kB, NF-Y. Low-dose fractionated
radiation can be used as an adjuvant for chemotherapy [27].
Heat stress induced 100-fold increase in the production of
heat shock proteins, and prevented the NF-kB activation
(nuclear translocation), may ultimately promote apoptosis
in OSCC Ca9-22 cell line [28]. Hyperthermia induced apop-
tosis in OSCC cells (wild-type p53), accompanied by decrease
of the gene expression of IL-12. On the other hand, IL-12Rb1
increased in the mutated p53 cells. p53 status is a useful
candidate for a predictive indicator of the effectiveness in
hyperthermic therapy [29].
Molecular inhibition of epidermal growth factor receptor
(EGFR) signaling is a promising cancer treatment strategy.
Treatment of OSCC cells with an anti-EGFR monoclonal anti-
body, Cetuximab (C225, Erbitux) and an EGFR tyrosine kinase
inhibitor (TKI), AG1478, which target the extracellular and
intracellular domains of the receptor, respectively, inhibited
phosphorylation of EGFR and its downstream effector mole-
cule Akt and amplified the induction of Fas-mediated apop-
tosis. The pro-apoptotic activity of EGFR inhibitors in OSCC
cells depends on the extrinsic pathway of the caspase cas-
cade accompanied by the down-regulation of cellular FLICE-
inhibitory protein (c-FLIP) [30].
3.1.2. Natural products
Essential oil of a perennial small herbal plant induced apop-
tosis via MAPK activation, based on the inhibition of MAPK
kinase inhibitor [31]. Soft coral extract induced apoptosis in
OSCC (SCC4, SCC9, SCC25) [32]. Ethanol extract of freeze-
dried black raspberries suppressed the proliferation of OSCC
cell lines without affecting viability, inhibited the production
of vascular endothelial growth factor (VEGF), and induced
both apoptosis and terminal differentiation. This extract may
be a promising candidate for use as a chemopreventive agent
in persons with oral epithelial dysplasia [33].
Theaflavin-3,30-digallate, a polyphenol in black tea,
induced apoptosis in HSC-2 cell by its prooxidant action (ele-
vation of reactive oxygen species (ROS) production) whereas
normal humangingival fibroblast (GN)wasmore resistant [34].
Green tea polyphenol induced apoptosis in OSCC cell line
accompanied by the gradual decline of mitochondrial func-
tion. The cells deleted of caspase-3 gene did not undergo
apoptosis. This suggests that green tea polyphenol-induced
apoptosis is a mitochondria-targeted, caspase-3-executed
mechanism [35]. Green tea polyphenols (catechins) induced
176 H. Sakagamiapoptosis in OSCC cells, and p58/KIP2 is a determinant pro-
survival factor for cell protection from green tea polyphenol-
induced apoptosis [36]. Curcumin aloneor in combinationwith
tea polyphenols inhibited the oral carcinogenesis in hamsters,
possibly by suppressing the cell proliferation, induction of
apoptosis and angiogenesis [37].
Stilbenes (resveratrol, piceatannol, rhaponticin), stilbene
trimers (sophorastilbene A, ()-e-viniferin), a stilbene dimer
((+)-a-viniferin) and flavonoids (kaempferol, fisetin, querce-
tin, isoliquiritigenin, butein) inducedactivationof caspase-3, -
8 and -9, and internucleosomal DNA fragmentation in human
promyelocytic leukemia HL-60 and OSCC (HSC-2) cells [38].
Ovatodiolide, a diterpenoid from a Chinese herb, induced
G2/M arrest and apoptosis in OSCC cell line Ca9-22 by N-
acetyl-L-cysteine (NAC)-inhibitable ROS generation [39]. Shi-
konin, a naphthoquinone pigment isolated from the Chinese
herbal therapeutic, Zicao, has been shown to exhibit anti-
oxidant and anticancer effects. Shikonin induced apoptosis in
human OSCC (Tca8113) cells via inactivation of NF-kB path-
way [40]. Paradol, a pungent phenolic compound found in
ginger and other Zingiberaceae plants, induced apoptosis in
OSCC (KB) cells through a caspase-3-dependent mechanism
[41].
3.1.3. Inhibitors
Cyclooxygenase-2 (COX-2), an enzyme that catalyzes the
synthesis of prostaglandins (PGs), is made inducible by var-
ious stimuli such as inflammation. COX-2 is commonly over-
expressed in a variety of premalignant and malignant
conditions including oral leukoplakia and SCC. Overexpres-
sion of COX-2 plays an important role in the development and
progression of different cancers. Immunohistochemical ana-
lysis demonstrated that expression of COX-2 and E2 promoter-
binding factor-1 (E2F-1) proteins was increased in both oral
dysplasia and SCC compared to the normal epithelium. A
selective COX-2 inhibitor, NS398, suppressed PGE2 level, and
expressions of COX-2, pRb and E2F-1 proteins, and induced
G1 arrest and apoptosis [42]. Apoptosis-inducing activity of
four selective COX-2 inhibitors (celecoxib, NS-398, nimesu-
lide, meloxicam) was compared using OSCC (KB) cells. Cel-
ecoxib and NS-398 strongly suppressed the proliferation of KB
cells at 10—100 mM, whereas nimesulide and meloxicam are
less potent. All COX-2 inhibitors increased COX-2 protein
expression but suppressed PGE2 production. Only celecoxib
induced apoptosis. Celecoxib is a good therapeutic candidate
for treating OSCC through the suppression of cell prolifera-
tion and the induction of apoptosis in a COX-2 independent
manner [43]. Sulindac, a non-steroidal anti-inflammatory
drug (NSAID), induced growth inhibition and apoptosis in
OSCC (SCCa), and caused up-regulation of the protein and
mRNA expression levels of COX-2 and PPARg. Treatment of
antisense PPARg oligonuleotides abolished sulindac’s growth
inhibitory effect, suggesting that up-regulation of PPARg
expression and activation may be, at least partially, respon-
sible for sulindac’s antiproliferative effect [44].
Protein kinase C (PKC) inhibitor safingol induced apoptosis
in OSCC cells, accompanied by release of endonuclease G
from mitochondria and translocated to nucleus [45]. Safingol
induced the apoptosis in OSCC by mechanism involved with
increase of Bmi and decrease of Bcl-xL and phosphorylated
focal adhesion kinase (FAK) [46]. UCN-01 (7-hydroxystauros-
porine), a PKC inhibitor, also induced apoptosis and G1 arrestin OSCC cell lines. HSC-3 (primary-type OSCC) were less
sensitive than LMF4 cells (metastatic-type OSCC)[47].
Protein phosphatase inhibitors, okadaic acid (OA) and
calyculin A (CA), induced apoptosis in three OSCC cell lines
(SCC-25, SCCKN, SCCTF) [48]. Okadaic acid induced apoptosis
in OSCC (SCC-25) cells by enhancing the Fas and FasL expres-
sion [49].
Flavopiridol, a synthetic flavone, inhibited the growth (by
reducing the expressions of cyclin A, cyclin B and cyclin D1,
and cyclin-dependent kinases (CDK) activation kinase and
CDC25C) and induced apoptosis (by activating the Bcl-x path-
way) in OSCC cells [50].
Proteasome inhibitors, carbobenzoxy-L-leucyl-L-leucyl-L-
norvalinal, or lactacystin, induced apoptosis in OSCC cells,
but this was inhibited by antisense p27Kip1 oligonucleotide.
The accumulation of p27Kip1 may play an important role in
the apoptosis induced by proteasome inhibitor [51].
3.1.4. Hormone receptor ligands
15-Deoxy-D12, D14-prostaglandin (PG) J2, a proliferator-acti-
vated receptor g (PPARg) ligand, induced growth inhibition
and apoptosis in OSCC cells, whereas rosiglitazone and cigli-
tazone, thiazolidinedione family of PPARg activators, did not
exert a growth inhibitory effect. 15-PGJ2, but not other
PPARg activators, induced significant reduction of both phos-
phorylated and unphosphorylated Stat3 (signal transducer
and activator of transcription). This suggests that 15-PG
induces apoptosis in OSCC by PPARg-independent pathways
[52]. Cyclopentenone 15-Deoxy-D12, D14 PGJ2 induced apop-
tosis in OSCC (B88) cell lines by down-regulation of the
constitutive and IL-6-mediated JAK (Janus kinase) phosphor-
ylation as well as Stat3 phosphorylation. The apoptosis-indu-
cing activity of this compound required the a,b-unsaturated
ketone structure within the cyclopentenone ring [52].
All-trans retinoic acid (ATRA) and 1a,25(OH)2vitamin D3
(calcitriol) suppressed the cell proliferation and induced
apoptosis in OSCC (KB) cells, upregulated sensitivity of the
chemotherapeutics drugs and down-regulated several angio-
genesis factors and survivin [53]. Retinoic acid induced
apoptosis in OSCC (Tca83) cells by enhancement of Fas gene
transcription and translation, without change in FasL expres-
sion [54].
3.1.5. Gene manipulations
RNAi targeting urokinase-type plasminogen activator recep-
tor (u-PAR) induced apoptosis as well as oral cancer invasion
and metastasis [55]. Stable transfection of intracellular frag-
ment of Notch induced G0—G1 cell cycle arrest and apoptosis
in human tongue cancer cell line (Tca8113), accompanied by
down-regulation of Wnt-b-catenin, increase of p21 and p53
expression, and decrease in Skp2 (S-phase kinase-associated
protein 2) and Bcl-2 (B-cell lymphocytic-leukaemia proto-
oncogene 2) expression [56].
3.1.6. Others
Nitric oxide (NO) donor, nitroprusside (SNP), induced kera-
tinocyte differentiation markers at lower concentrations,
while it induced apoptosis at higher concentrations in human
immortalized keratinocytes (IHOK) and primary oral cancer
cells (HK4) [57]. NO generator (ONOO, SIN-1 and SNP)
induced apoptosis in OSCC (OSC-4) cells [16].
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3) cells, accompanied by the loss of mitochondrial membrane
potential and glutathione (GSH), without a concurrent
increase in ROS. The apoptosis-inducing activity of Se was
diminished by GSH or compounds that elevated the intracel-
lular GSH level, but augmented by buthionine sulfoximine
that reduced GSH level. These data suggest possible role of
GSH in the mitochondrial apoptosis of OSCC caused by Se
[58].
Arsenic trioxide induced toxic damage and apoptosis char-
acterized by caspase-3 activation, mitochondrial transmem-
brane potential collapse and G2/M arrest, but no change in
p16, p53 and Bcl-2, in OSCC cell line. Tubulins and mitochon-
dria may be the chief action position of arsenic trioxide [59].
Taurolidine, a derivative of the amino acid taurine,
induced apoptosis in two OSCC cell lines (SCC4, SCC15), in
contrast to the reference group treated with povidone iodine
or the untreated control group [60].
3.2. Head and neck squamous cell carcinoma
(HNSCC) (Table 2)
Cetuximab is a chimeric mouse/human monoclonal antibody
used to treat metastatic colorectal cancer and head and neck
cancer. The antibody binds to the EGFR, a signalling protein
that normally controls cell division. In some cancers, this
receptor is altered to cause uncontrolled cell division. Cetux-
imab blocks EGFR and stops the uncontrolled cell division.
Cetuximab induced apoptosis in HNSSC by inhibiting the MAPK
and Janus kinase (JAK)/STAT-3 pathways [61].
Combination treatment with 13-retinoic acid, interferon-
a2a and a-tocopherol apparently further inhibited the
growth of five squamous cell carcinoma of the head and neck
(SCCHN) in comparison to any single agent and two-drug
combinations. Three-drug combination induced significant
accumulation of the cells at S-phase and induced apoptosis.
These data supported the promising outcomes of the phase III
trial with a combination of these three drugs in patients with
advanced head and neck cancer in the adjuvant settings [62].
Galanin is a neuropeptide present in humans and other
mammals. It is a peptide consisting of a chain of 29 amino
acids (or 30 amino acids in humans).Galanin is formed by the
cleavage of a prepropeptide encoded by a gene known as
GAL. Galanin induced apoptosis in galanin receptor-trans-
fected HNSCC cell line with mutant p53 [63].
Alterations in histone acetylation status have been impli-
cated in carcinogenesis. Histone deacetylase inhibitors, such
as suberoylanilide hydroxamic acid, can potentially reacti-
vate aberrantly silenced genes by restoring histone acetyla-
tion and allowing gene transcription. Suberoylanilide
hydroxamic acid induced both mitochondrial pathway of
apoptosis (cytochrome c release, caspase-3, caspase-9 acti-
vation) and extrinsic apoptosis pathway (increased Fas and
Fas ligand (FasL) expression, activation of caspase-8, clea-
vage of Bid), having comparatively little activity against
precancerous and normal oral cells [64].
Vitamin E succinate (a-TOS) induced apoptosis in five
HNSCC cell lines (JHU-011, JHU-013, JHU-019, JHU-022,
JHU-029) accompanied by elevation of ceramide, sphingo-
myelinase activity and p53. On the other hand, the amounts
of nuclear factor kB, Bcl-2, and Bcl-X(L) proteins werereduced. Intraperitoneal administration of vitamin E succi-
nate slowed the growth of JHU-022 solid tumor xenograft in
immunodeficient mice [65].
An active component of OK-432, a streptococcal prepara-
tion, induced apoptosis in human HNSCC cell line by the
activation of caspases through p53-independent pathway
via TLR4 signaling [66].
The expression of E1A induced down-regulation of the
expression of EGFR that was overexpressed in four HNSCC cell
lines (Table 2). Overexpression of an exogenously introduced
EGFR blocked E1A induction of apoptosis in these cells. These
data suggest that E1A induces apoptosis by novel pathway
involving EGFR [67].
Oral administration of vesnarinone, a cardiotonic, to a
patient with histopathological recurrent oral cancer with
well-differentiated squamous cell carcinoma, resulted in
complete remission of the tumour [68].
3.3. Salivary gland carcinoma
Slindac, a non-steroidal anti-inflammatory drug (NSAID),
induced a significant decrease in cell proliferation and an
increase in apoptosis in two salivary gland adenocarcinoma
cell lines (HSY, HSG) [69].
4. Anti-apoptotic mechanism in OSCC
(Table 3)
OSCC (Ho-1-N-1 SP) cells survived even under treatment with
various agents (5-FU, carboplatin), possibly due to high level
expression of ABC transporters (ABCB1, ABCG2) and anti-
apoptotic protein (CFLAR, BCL2, BCL2A1) [70].
Hyperthermia-resistant human squamous cell carcinoma
(SAS) cell: higher expression of Bcl-2, Bcl-xL, NF-kB, COX-2,
STAT3, IL-6, IKKa/1) [71]. The imbalance between expression
of anti-apoptotic and pro-apoptotic Bcl-2 family genes may
promote survival in the oral cell lines [72]. The frequency of
bcl-2 expression was associated with tumor histologic grade
and decrease in apoptotic index in tongue SCC [73].
()-Epigallocatechin-3-gallate (EGCG), a major compo-
nent of green tea, induced p57, a cyclin-dependent kinase
and apoptosis inhibitor, in a dose- and time-dependent man-
ner in normal keratinocytes, but not in OSCC (SCC25, OSC2)
cells. The chemopreventive effect of green tea polyphenols
may involve p57-mediated cell cycle regulation in normal
epithelial cell [74].
Pairedboxgene9 (Pax9) andc-mybare transcription factors
that regulate the expression of the genes involved inmediating
cell proliferation, resistance to apoptosis, andmigration. Pax9
and c-myb expressions in KB cells seem to be essential for cell
growth, and survival was enhanced by c-myb. Disruption of the
function of c-myb and Pax9 induced G0 arrest [75].
The mouse double minute 2 (MDM2) plays a pivotal role in
radiotherapy by down regulating p53. A functional T-to-G
polymorphism at nucleotide 309 in MDM promoter intron 1
(SNP309) influences transcription activity. A G-to-C SNP at p53
codon 72 results in an Arg/Pro polymorphism, which is asso-
ciated with apoptosis induction potential and p53 mutation
status. The MDM2 SNP309 G/G polymorphism was associated
with poor overall survival in advanced OSCC and the overall
survival and disease-free survival of irradiated patients. The
Table 1 Substances that induce apoptosis in OSCC cells.
Inducers Possible mechanism Reference
Antitumor agents
5-FU [16,26,97]
Cisplatin (CDDP) Survivin #, FADD ", no change in NF-kB CDKIs " [16,17,18,26,80]
Carboplatin (CBDCA) Cleavage of Bax-alpha and Bcl-x(L) [20,21]
Paclitaxel [22]
Docetaxel BAX " [23]
Peplomycin, bleomycin G2-M block [16,24,25]
Radiation, g-ray, Cs [16,26,27]
Heat shock, hyperthermia IL-12 # [28,29]
Anti-EGFR mAb, EGFR TKI c-FLIP # [30]
Natural products
Essential oil [31]
Soft coral extracts [32]
Black raspberry extract [33]
Theaflavin-3,30-digallate [34]
Green tea polyphenols p57/KIP2 # [35,36,74]
Curcumin [37]
Stilbenes, flavonoids [38]
Diterpenoid [39]
Shikonin, a naphthoquinone pigment NF-kB # [40]
Paradol [41]
Inhibitors
Selective COX-2 inhibitor, NS398, celecoxib [42,43,44]
PKC inhibitor safingol, 7-hydroxystaurosporine [45,46,47]
Phosphatase inhibitors: Okadaic acid calyculin A Fas receptor ", FasL " [48,49]
CDK inhibitor, flavopiridol CDKs # [50]
Proteasome inhibitors p21Kip1 accumulation [51]
Ligands to hormone receptors
Cyclopentenone 15-deoxy-D12, D14- PGJ2 JAK signalling #, Stat3 # [52]
All-trans retinoic acid [53]
1a,25(OH)2vitamin D3 Survivin #, VEGF # [53]
Gene manipulation
siRNA targeting u-PAR [55]
Notch overexpression [56]
Others
NO generator, ONOO, SIN-1 and SNP [16,57]
Selenium compounds GSH # [58]
Arsenic trioxide [59]
Taurolidine [60]
178 H. Sakagamicombination of MDM2 SNP309 G/G and p53 codon 72 Arg/Arg
polymorphism is associatedwith the worst overall survival and
disease-free survival. BothMDM2SNP309 andp53codon72 SNP
could beuseful factors forevaluating theoutcomeofadvanced
OSCC treated with adjuvant radiation [76].
p58/KIP2 is a determinant pro-survival factor for cell pro-
tection from green tea polyphenol-induced apoptosis [36].
The nu/nu mice inoculated with Mn-SOD antisense-trans-
fected SCC cells showed prolonged survival time, as com-
pared with mice inoculated with control vector-transfected
SCC cells after treatment with antitumor agents such as 5-FU,
peplomycin, CDDP or g-ray. SCC cells transfected with Mn-
SOD antisense group showed higher incidence of apoptosis
than that transfected with empty vector. Mn-SOD may act as
a negative regulator of apoptosis [77]. OSCC cell lines with
lower Mn-SOD activity were easily committed to apoptosisupon treatment with 5-FU, peplomycin or g-rays, than those
with higher Mn-SOD. This suggests that Mn-SOD negatively
regulates the apoptosis by these inducers [78].
5. Potentiators of apoptosis (Table 4)
Apoptosis induction may be potentiated by reversing the
anti-apoptotic mechanism.
5.1. Chemotherapeutic drugs
CDDP administered for 24 h before 5-FU treatment for 48 h
induced apoptosis in human oral cancer cells (B88) more
efficiently than simultaneous administration of CDDP and 5-
FU or the sequential treatment of 5-FU followed by CDDP [79].
Table 3 Anti-apoptotic mechanism in OSCC cells.
Anti-apoptotic mechanism Reference
ABC transporters: ABCB1, ABCG2 [70]
Bim ", Bcl-xL #, phosphorylated FAK # [46]
Bcl-2, Bcl-xL, NF-kB, COX-2, STAT3,
IL-6, IKKa/1
[71,73]
Pax9, c-myb [75]
SNP 309 and p53 codon 72 polymorphisms [76]
Cyclin-dependent kinase inhibitor p57/KIP2 [36,74]
Mn-SOD [77,78]
Table 2 Apoptosis induction in HNSCC cells.
Inducers Possible mechanism Reference
Cetuximb [61]
Retinoic acid + IFN-a + vitamin E [62]
Gelanin [63]
HDA inhibitor, suberoylanilide hydroxamic acid [64]
Vitamin E succinate Ceramide ", p53 ", NF-kB #, Bcl-2 #, Bcl-xl # [65]
OK-432, a streptococcal preparation p53-independent pathway via TLR4 signaling [66]
Expression of E1A EGFR # [67]
Vesnarinone, cardiotonic (clinical trial) [68]
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regulation of cyclin-dependent kinase inhibitors (CDKIs) such
as p21/Waf-1, p27/Kip1 and p15/INK4a in HNSCC cell lines
(HN5, HN6), and sensitized the cells to apoptosis induced by
CDDP. Tamoxifen stimulated the secretion of TGF-b1, and
anti-TGF-b1 blocking antibody prevented both the blockade
of cellular proliferation and increased expression of CDKIs.
This suggests the role of TGF-b1 for the tamoxifen stimula-
tion of cisplatin-induced apoptosis [80].
Hyperthermia is used as one of the treatment modalities
for various types of cancers, but the acquisition of thermo-
tolerance in cancer, through the induction of heat shock
proteins (Hsps), renders hyperthermia less effective. Pre-Table 4 Potentiators of apoptosis induction.
Potentiator Inducer
Antitumor agents
Cisplatin Agonistic Fas antibod
(CH11), 5-FU
Cs, 5-FU, CDDP LAK
Tamoxifen Cisplatin
IFN-g Hyperthermia, cispla
Inhibitors
Selective COX-2 inhibitor, etodolac Carboplatin (CBDCA)
HDA inhibitor, suberoylanilide
hydroxamic acid
CDDP
Others
Resveratrol Vincristin, adriamyci
paclitaxel
Glycerol X-irradiation
Infection of wild-type p53-encoding
adenovirus
X-irradiationtreatment of HSC-2 cells with IFN-g suppressed Hsp27 tran-
scription and promoter activity, and enhanced the induction
of cell death by hyperthermia and cisplatin treatment [81].
5.2. Inhibitors
Etodolac, a selective COX-2 inhibitor, enhanced the carbo-
platin (CBDCA)-induced apoptosis of OSCC (SCC-25) cell line
through the suppression of FAP-1 (anti-apoptotic tyrosine
phosphatase) expression, although etodolac alone did not
induce the apoptosis [82].
Histone deacetylase inhibitor, suberoylanilide hydroxamic
acid, enhanced CDDP-induced apoptosis in the OSCC cell line
(HSC-3), by rapidly up-regulating the endoplasmic reticulum
(ER) stress-associated events such as the sustained phosphor-
ylation of eukaryotic transition initiation factor-2 (eIF2), acti-
vation of protein phosphatase 1 and Akt dephosphorylation
[83]. Co-administration of low-dose cisplatin (4 mg/ml) and
suberoylanilide hydroxamic acid (2 mM) synergistically induced
cytotoxicity andapoptosis inOSCC (Tca8113,KB) cell lines [84].
5.3. Others
Resveratrol (trans-resveratrol) is a phytoalexin produced
naturally by several plants when under attack by pathogensPossible mechanism Reference
y Soluble Fas", Bcl-2# [19,79]
[26]
CDKIs", TGF-b1 secretion " [80]
tin, ATLA Hsp27 transcription and
promoter activity #
[81,88]
FAP-1 # [82]
Protein phosphatase ", Akt
dephosphorylation
[83,84]
n, Bcl-2 #, MDR1 # [85]
[86]
[87]
180 H. Sakagamisuch as bacteria or fungi, and found in the skin of red grapes
and is a constituent of red wine. Resveratrol down-regulated
the expression of Bcl-2 and MDR1, and enhanced the sensi-
tivity of human epidermoid carcinoma KBv200 cells [85].
Pretreatment with glycerol enhanced the effectiveness of
X-irradiation in Ca9-22 cells bearing a mutant p53. Glycerol
restored the DNA-binding activity of mutant p53 for a p53-
consensus sequence to levels similar to that of wild-type p53
[86].
Infection with wild-type p53-encoding adenovirus alone, or
X-irradiation alone, significantly inhibited the growth of OSCC
(HSC-4 and SAS) cells, but combined treatment was most
effective, even in mutant p53-accumulated HSC-4 cells [87].
ATLA and interferon-g synergistically stimulated the apop-
tosis in OSCC cell lines [88].
6. Induction of non-apoptosis
As compared with the studies of apoptosis induction in OSCC,
those of non-apoptosis induction are limited. Morin
(3,5,7,20,40-pentahydroxyflavone) induced G2/M arrest,
without induction of apoptosis in human OSCC cells, via
inhibition of AKTactivation [89]. Intratumoral laser illumina-
tion of OSCC transplated nude mice induced necrosis, but not
apoptosis, in OSCC cells [90].
We have recently reported that a,b-unsaturated ketones
such as 1-trichloroacetyl-3-bromo-2-methoxyazulene and 1-
trichloroacetyl-3-chloro-2-ethoxyazulene induced autopha-
gic cell death characterized by the vacuolization detected by
transmission electron microscopy, and the granular distribu-
tion of acridine orange and translocation of LC3-GFP into the
autophagosome of OSCC (HSC-4) cells. Although HL-60 cells
are easily committed to apoptosis by many inducers, this cell
line did not express apoptosis markers, such as internucleo-
somal DNA fragmentation and caspase activation, upon treat-
ment with 4,4-dimethyl-2-cyclopenten-1-one, a-methylene-
g-butyrolactone, 5,6-dihydro-2H-pyran-2-one, 3,3,3-tri-
fluoro-2-hydroxy-1-phenyl-1-propanone, codeinone (an oxi-
dative product of codeine) or morphinone (an oxidative
metabolite of morphine) [91]. We found that 3,3,3-tri-
fluoro-2-hydroxy-1-phenyl-1-propanone induced autophagic
cell death (characterized by acridine and LC3-GFP accumula-
tion in the autophagosome) in human OSCC cell lines (HSC-2,
HSC-4) [92]. Furthermore, morphinone induced the forma-
tion of autophagosome engulfing organelles in HL-60 cells.
The addition of N-acetyl-L-cysteine (NAC) reduced the cyto-
toxic activity of codeinone by 30-folds, whereas other anti-
oxidants (cysteine, ascorbate, catalase) and metals (FeCl3,
CoCl2, CuCl2) were almost inactive. Similarly, the cytotoxic
activity of 4,4-dimethyl-2-cyclopenten-1-one, a-methylene-
g-butyrolactone, 5,6-dihydro-2H-pyran-2-one was almost
completely eliminated by NAC. This suggests that the cyto-
toxicity of a,b-unsaturated ketones is generated by the
interaction between the b-position of the a,b-unsaturated
carbonyl moiety and SH group of any targeted molecules (the
so-called ‘‘non-sterically hindered Michael acceptor’’). We
also found that morphinone induced a significant reduction of
mitochondrial size. It is not clear at present whether this
resulted from the perturbation of mitochondrial morphogen-
esis or the fragmentation of mitochondria as recently
reported in Bax/Bak double knockout mouse embryonicfibroblast [93]. It has been recently reported that autophagy
selectively degrades mitochondria, blocking the vicious cycle
between defective mitochondria and ROS. These data sug-
gest the mitochondrial target of autophagy.
7. Tumor-specificity (Table 5)
There are very few reports available that have dealt with the
tumor-specificity of natural and synthetic compounds. Thea-
flavin-3,30-digallate showed a concentration and time-depen-
dent inhibition, with the OSCC cells more sensitive than the
normalGN46fibroblasts [34]. Morin showedhigher cytotoxicity
against OSCC than normal oral mucosa cells (NOMC) (TS = 1.6)
whereas quercetin, kaempferol, datiscetin and galangin
showed little or no tumor-specificity (TS = 1.03, 1.06, 1.00
and1.08, respectively) [89].Chemopreventiveeffects of green
tea polyphenols may involve p57-mediated cell cycle regula-
tion in normal epithelial cells [74].Histonedeacetylase inhibits
suberoylanilide hydroxamic acid induced growth inhibition and
apoptosis induction in HNSCC cell lines, but had limited effects
on premalignant and normal cells [64]. Based on these back-
grounds, we have surveyed a total of 1000 compounds for their
tumor-specificity. The tumor-specific cytotoxicity index (TS)
was determined by the ratio of the mean 50% cytotoxic con-
centration (CC50) against normal human oral cells (gingival
fibroblast (HGF), pulp cell (HPC), periodontal ligament fibro-
blast (HPLF)) to that against human OSCC cell lines (HSC-2,
HSC-3, HSC-4, NA, Ca9-22), submandibular gland carcinoma
(HSG) [38,94,95] (Table 5). Preparations of normal cells from
the extracted teeth and periodontal tissues have been
approved by the intramural ethic committee after obtaining
the informed consent from the donors. The compounds ana-
lyzed were mostly isolated and identified by our groups.
7.1. Flavonoid-related polyphenols
Flavonoids, generally, showed weak tumor-specificity
(TS = 1.2—4.0). Licochalcone B, a chalcone derivative with-
out an isoprenoid group, showed the highest TS value of 31.7.
Isoprenoid-substituted chalcone, prenylated isoflavone and
genistein had higher cytotoxicity, but without high tumor-
specificity, suggesting that the prenylation itself is not neces-
sary for the tumor-specificity. Among the benzophenones,
compounds with two isoprenoid groups had higher cytotoxi-
city than the monoprenylated compound, but with minor TS
values. Anthraquinones exhibited relatively higher TS values.
Among them, emodin and aloe-emodin, without glycosyla-
tion, were the most potent (TS = 8.5 and >18.6, respec-
tively). Stilbenes (resveratrol, piceatannol, rhaponticin),
stilbene trimers (sophorastilbene A, ()-e-viniferin), a stil-
bene dimer ((+)-a-viniferin) (TS = 1.4—3.6) and flavonoids
(kaempferol, fisetin, quercetin, isoliquiritigenin, butein)
(TS = 1.4—4.7) gave lower TS values.
7.2. Coumarins
Coumarin itself and its 7-hydroxy-, 6-methoxy-7-hydroxy and
5,6-dimethoxy-derivatives were relatively non-toxic to all
cell lines. Its 6,7-dihydroxy derivatives (esculetin) revealed a
tumor cell line-specific cytotoxicity (TS > 5.1). Higher
tumor-specificity of 4-methyl (TS > 8.3), 3,4-dimethyl
Table 5 Tumor-specificity of various groups of compounds against OSCC cells.
Compounds TS (range) (no. of compounds)
Flavonoids
Flavones, flavonols, isoprenylated flavonoids 1.2  0.6 (0.3—3.2) (n = 36)
Flavonoids 3.3  4.0 (0.8—31.7) (n = 27)
Isoprenylated flavonoids 2.1  0.4 (1.6—3.0) (n = 22)
2-Arylbenzofurans 1.2  0.2 (1.0—1.5) (n = 6)
Benzophenones 1.7  0.4 (1.2—2.3) (n = 5)
Xanthones 1.3  0.4 (n = 9)
Anthraquinones 3.8  4.9 (1.0—18.6) (n = 13)
Phenylbutanone glucoside 2.4 (1.5—3.3) (n = 2)
Stilbene glucoside 1.8  0.8 (1.0—2.6) (n = 3)
Naphthalene glucosides 1.3 (1.1—1.4) (n = 2)
Stilbenes 3.0  1.2 (1.4—4.7) (n = 6)
Coumarins 2.4  3.0 (1.0—11.0) (n = 23)
Tannin-related compounds
Procyanidins 4.8  2.3 (1.0—7.4) (n = 6)
Flavonoids 1.1  0.1 (1.0—1.2) (n = 4)
Monohydrolyzable tannins 1.5  0.5 (1.0—2.5) (n = 7)
Oligomeric hydrolysable tannins 1.4  0.2 (1.2—1.5) (n = 3)
Macrocyclic ellagitannins 4.4  2.7 (2.3—8.2) (n = 4)
Terpens
Triterpenes 1.5  0.7 (0.7—2.8) (n = 8)
Triterpene glycosides 1.4  0.5 (1.0—2.4) (n = 21)
Triterpenes, triterpene glycosides, chromones 1.0  0.1 (0.8—1.3) (n = 20)
Cycloartane glycosides 1.1  0.2 (0.9—1.4) (n = 7)
Furostaol glycosides 2.5  4.1 (0.4—17.0) (n = 17)
Ketones
a,b-Unsaturated ketones 1.2  0.3 (0.6—1.9) (n = 26)
Cyclice a,b-unsaturated ketones >229.0 (n = 1)
a-Hydroxyketones 5.7  6.0 (1.0—17.6) (n = 8)
b-Diketones 1.8  1.4 (0.3—6.3) (n = 22)
Trifluoromethylketones 2.6  1.6 (n = 6)
Azulenequinones 2.6  2.3 (1.0—10.2) (n = 27)
Bacterial products
Anthracyclines >167  89 (n = 4)
Mitomycin C >29 (n = 1)
Bleomycin, peplomycin >3.8  0.2 (n = 2)
Nocobactines 62.0 (43.9—80.0) (n = 2)
Others
Vitamin K2 derivatives 1.9  0.2 (1.7-2.0) (n = 3)
Prenylalcohols 1.3  0.3 (1.0-1.8) (n = 5)
Azulenes 1.7  1.0 (0.8—5.7) (n = 27)
Trihaloacetylazulenes 6.5  10.7 (n = 26)
Tropolones 2.6  1.8 (1.0—9.9) (n = 27)
Berberines 3.8 (3.6—4.0) (n = 2)
3,5-Dibenzoyl-1,4-dihydropyridines >43.0 (>33 to >53) (n = 2)
Styrylchromones 7.3  6.1 (1.1—17.4) (n = 6)
Isoxazole derivatives 1.2  0.2 (0.9—1.6) (n = 24)
Antioxidants
Epigallocatechin gallate (EGCG) 4.1 (n = 1)
Catechin 1.0 (n = 1)
Quercetin 3.3 (n = 1)
Isoliquiritigenin 4 (n = 1)
Ascorbic acid (vitamin C) 2.5 (n = 1)
Gallic acid 1.1 (n = 1)
Chlorogenic acid 1.7 (n = 1)
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Table 5 (Continued )
Compounds TS (range) (no. of compounds)
Curcumin 1.7 (n = 1)
Morin 1.64 (n = 1)
Quercetin 1.06 (n = 1)
Kaemferol 1.06 (n = 1)
Datiscetin 1.00 (n = 1)
Galangin 1.08 (n = 1)
Data derived from [38,94,95].
182 H. Sakagami(TS > 9.3) and 3,4-cycloalkyl derivatives (TS > 11.0) than
6,7-dihydroxycoumarin may be due to their higher lipophi-
licity.
7.3. Tannins-related compounds
Procyanidin B-2 (MW 578) (TS = 5.8), procyanidin C-1 (MW
866) (TS = >6.7) and procyanidin oligomers (MW 3170)
(TS > 7.4) had higher cytotoxicity and tumor-specific cyto-
toxicity against OSCC cells than did catechin (MW 290)
(TS = 1.0), ()-epicatechin (MW 290) (TS = 4.0) and ()-epi-
gallocatechin gallate (EGCG) (MW 458) (TS = 4.1).
Among hydrolyzable tannins (which contain glucose in the
core of the molecule), three oligomeric hydrolyzable tannins
(MW 1854—1873) had an approximately two-fold higher cyto-
toxicity than seven monomeric hydrolyzable tannins. Macro-
cyclic hydrolyzable tannins (oenothein B, woodfordin C,
camelliin B, woodfordin D) (MW 1568—2506) exhibited
one order higher cytotoxicity than monomeric hydrolyzable
tannins. The tumor-specific cytotoxicity of macrocylic hydro-
lyzable tannins (TS = 2.7—8.2) was two- or three-fold higher
than monomeric (TS = 1.0—2.5) or oligomeric hydrolyzable
(TS = 1.2—1.5) tannins. On the other hand, gallic acid (MW
170) (TS = 1.1), methylgallate (MW 184) (TS = 1.3), ellagic acid
(MW 302) (TS = 1.0) and chlorogenic acid (MW 354) (TS = 1.7)
hadmuch lower tumor-specificcytotoxicity.Thesedatasuggest
that a more condensed structure, with (hydrolyzable tannins)
or without glucose in the molecule (condensed tannins such as
procyanidin oligomers), increases the tumor-specificity.
7.4. Terpenoids
Generally, terpenoids had low tumor-specificity (TS = 0.5—
2.4), except for oleanolic acid (TS > 2.8) and 22a-methox-
yfurostanol monodesmosides (TS = 7.4, >17,4).
7.5. Ketones
The cytotoxic activity of a,b-unsaturated ketones declined
with the introduction of methyl group at C-3 (b) or the
addition of N-acetyl-L-cysteine (NAC), suggesting that their
cytotoxicity is generated by the interaction between the C-3
and SH group of targeted molecules. Codeinone and morphi-
none (oxidative metabolites of codeine or morphine, respec-
tively) containing a a,b-unsaturated ketone backbone
showed lower tumor-specificity (TS = 3.8 and 3.1, respec-
tively). Cyclic a,b-unsaturated ketones, such as 3-arylidene-
1-(4-nitrophenylmethylene)-3,4-dihydro-1H-naphthalen-2-
ones exhibited unusually high tumor-specificity (TS > 229).Among 8 hydroxyketones, deferiprone (TS > 17.6), mimo-
sine (TS > 7.9), tropolone (TS > 4.1) and hinokitiol
(TS = 10.7) had the highest tumor-specific cytotoxicity. On
the other hand, maltol (TS = 1.0), kojic acid (TS = 1.4), 3-
methyl-1,2-cyclopentanedione (TS = 1.3), 1,2-cyclohexane-
dione (TS = 1.2) had lower tumor-specificity.
Among 23 b-diketones, 3-formylchromone was the most
tumor-specific (TS = 6.3), followed by (+)- and ()-3-(tri-
fluoroacetyl)camphor (TS = 4.4), 4,4,4-trifluoro-1-phenyl-
1,3-butanedione (TS = 3.4) and ()-3-(trifluoroacetyl)cam-
phor (TS = 3.3); others including curcumin were much less
active (TS = 0.9—2.2).
Among 27 azulenequinone derivatives, 3-phenoxy-1,5-
azulenequinone (TS > 8.5) and 7-isopropyl-3-(4-methylani-
lino)-2-methyl-1,5-azulenequinone (TS = 10.2) had highest
tumor-specificity and apoptosis-inducing activity (caspase
activation). Among 27 tropolone derivatives, 5-aminotropo-
lone was the most tumor-specific (TS = 9.9) and had the
highest apoptosis-inducing activity.
7.6. Synthetic compounds
Among 27 azulene derivatives, 2-acetylaminoazulene
(TS > 3.6), diethyl 2-chloroazulene-1,3-dicarboxylate
(TS > 5.7) and methyl 7-isopropyl-2-methoxyazulene-1-car-
boxylate (TS = 2.4) had the highest tumor-specificity. Chlor-
ination of azulene resulted in the elevation of both
cytotoxicity and tumor-specificity, while fluorination of the
same compound was not so effective.
There was no apparent difference between the cytotoxic
activity of 2-methoxyazulenes and 2-ethoxyazulenes. Tri-
chloroacetylazulenes generally gave higher cytotoxicity
and tumor-specificity as compared with the corresponding
trifluoroacetylazulenes. Substitution of chlorine, bromine or
iodine at the C-3 position further enhanced their cytotoxicity
to four tumor cell lines. Among 20 trihaloacetylazulene
derivatives, 1-trichloroacetyl-3-bromo-2-methoxyazulene
and 1-trichloroacetyl-3-chloro-2-ethoxyazulene had the
highest tumor-specificity (TS = >3.5 and>2.5, respectively).
Berberines exhibited some tumor-specificity (TS = 3.6—
4.0). Two 3,5-dibenzoyl-1,4-dihydropyridines had higher
tumor-specificity, but only weakly induced apoptosis markers
(DNA fragmentation, caspase activation). All six styrylchro-
mones had higher cytotoxic activity against tumor cell lines
than against normal cells. Styrylchromones, with one to
three methoxy groups, had higher tumor-specificity and
water solubility (TS = 5—17) and induced DNA fragmentation
and caspase-3, -8 and -9 activation. Twenty-four 3-acetyl-
and 3-benzoylisoxazole derivatives exhibited much lower
tumor-specificity (TS = 0.9—1.6).
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G1 DNA content, DNA fragmentation, PARP cleavage) via
activation of Bcl-x in OSCC cell lines [50].
7.7. Antitumor antibiotics
Doxorubicin, an anthracycline antibiotic isolated from Strep-
tomyces peucetius var. caesius has been used for the treat-
ment of cancer of the bladder, breast (in combination with
other anticancer agents) and prostate, but is, however, sus-
pected to be a human carcinogen. Doxorubicin, used as a
positive control in our screening system, exhibited the highest
tumor-specific cytotoxic activity (TS = 255.0). It activated
caspase-3, -8 and -9 in both OSCC (HSC-2) and promyelocytic
leukemia HL-60 cells, but only induced internucleosomal DNA
fragmentation in HL-60 cells. Western blot analysis showed
that doxorubicin did not significantly change the intracellular
concentration of Bcl-2, Bax or Bad in HL-60 cells. Real time
PCR analysis showed that HPC cells (normal) expressed the
highest amount of mdr1 mRNA, followed by HSC-2
(tumor) > HGF (normal) > HSC-3 (tumor) > HPLF (nor-
mal) > HSG (tumor) > HL-60 (tumor). These data suggest that
mdr1 expression in the tumor cells seems to be unrelated
to the tumor-specificity of doxorubicin. Other anthracyclines
such as mitoxantrone (TS > 259) and daunorubicin (TS > 164)
produced comparable tumor-specificity with doxorubicin.
Idarubicin exhibited slightly lower cytotoxicity and tumor-
specificity (TS = 47). On the other hand, the tumor-specificity
of other groups of antitumor antibiotics such as mitomycin C
(TS > 29), bleomycin (TS > 3.7) and peplomycin (TS > 4.0)
was much lower. This confirms the antitumor potential of
anthracylines for the treatment of OSCC.
Nocobactins NA-a (NBNAa) and NA-b (NBNAb) are myco-
bactin-like siderophores, which may play a role in the uptake
of iron from the proteins of the host by chelation of ferric ion
(Fe3+). These compounds exhibited high tumor-specificity
index (TS = 80.0 and 43.9, respectively).
7.8. Plant extracts
Poly-herbal extracts of Himalaya (HD-12, DLH-3073) exhib-
ited highly tumor-specific cytotoxicity to tumor cell lines
(TS = >1070 and >106, respectively) [96]. These extracts
produced radicals under alkaline condition and scavenged
O2
. The tumor-specificity and antioxidant properties sug-
gest their medicinal efficacy. The identification of the active
principle is essential.
8. Conclusion
The present review article demonstrated that OSCC cells can
be committed to either apoptosis or non-apoptosis, depend-
ing on the type or sensitivity of target cells. OSCC showed
different susceptibility of apoptosis, upon treatment with 5-
FU [97]. There was a considerable variation (approximately
10—20-fold) in drug-sensitivity of five OSCC cell lines. The
sensitivity to mitomycin C is in the following order (from
sensitive to resistant): HSC-2 (CC50 = 3.5 mM) > HSC-3
(9.7 mM) > Ca9-22 (16.4 mM) > HSC-4 (18.0 mM) > NA
(37.8 mM). The sensitivity to bleomycin is in the following
order: HSC-2 (CC50 = 4.6 mM) > HSC-3 (6.3 mM) > HSC-4(77.4 mM) > NA (91.6 mM) > Ca9-22 (111.6 mM). The sensitiv-
ity to peplomycin is in the following order: HSC-2
(CC50 = 9.9 mM) > HSC-3 (25.2 mM) > NA (143.2 mM) > HSC-
4 (175.8 mM) > Ca9-22 (216.9 mM) [94]. In general, OSCC
cells are relatively resistant to Fas-mediated apoptosis; this
may be due to a lower expression of FAS [5] or the cellular
FLICE-inhibitory protein (c-FLIP) [98]. A cyclooxygenase
(COX)-2 inhibitor (NS398) induced G0/G1 arrest, but no
apoptosis in OSCC cells [99]. On the other hand, human
glioblastoma cell lines (M059J, M059K, U373-MG and T98G)
has been reported to more exclusively commit to autophagy
(characterized by autophagosome formation, the accumula-
tion of Agp8p/Aut7p and LC3 (Atg8 homolog) in autophago-
some, and the inhibition of cell death by 3-methyladenine, an
autophagic inhibitor), upon exposure to radiation
(137Cs)[100], arsenic trioxide [101], ceramide [102] or temo-
zolomide (a new alkylating agent) [103] or doxorubicin [104].
Anthracyclines, with the highest tumor-specificity, also
induced non-apoptotic cell death in acute myeloblastic leu-
kemia [105], cardiomyocytes [106] and breast cancer cells
[107].
Another factor that determines the type of cell death is
the category of compounds that is used. a,b-Unsaturated
ketones (2-cyclohexen-1-one, 2-cyclopenten-1-one, 4,4-
dimethyl-2-cyclopenten-1-one, 2-cyclohepten-1-one, a-
methylene-g-butyrolactone, 6-dihydro-2H-pyran-2-one,
methyl 2-oxo-2H-pyran-3-carboxylate, codeinone, morphi-
none) and 3,5-dibenzoyl-1,4-dihydropyridines activated cas-
pase only marginally in HL-60 cells. Morphinone, an oxidative
metabolite of morphine, similarly induced non-apoptotic cell
death, accompanied by a significant reduction of mitochon-
drial size.
There is evidence that modulation of one form of cell
death may lead to another. Various stimuli (such as etopo-
side, TNF, hyperthermia, UV irradiation, ascorbic acid,
hydrogen peroxide) induced apoptosis (internucleosomal
DNA fragmentation) in various human leukemia cell lines
at relatively lower concentrations, whereas it induced necro-
tic cell death (smear pattern of DNA fragmentation) at higher
concentrations [108]. Recently, cross-talk between apoptotic
and autophagic pathways has been suggested [109,110].
This review reveals that tumor-specificity and apoptosis
induction do not always correlate with each other. This means
that having an apoptosis-inducing activity does not guarantee
its antitumor activity. Similar is true for autophagy-inducing
compounds, since a,b-unsaturated ketones which exclusively
induce non-apoptosis, have shown broad range of tumor-spe-
cificity (TS = 1—200). The tumor-specific cytotoxicity may be
affected by various factors such as the co-existence of both
hydrophilic and hydrophobic groups in the samemolecule, the
presence of an isoprenyl group, a halogen and/or a polycyclic
structure, a highly condensed structure, and lipophilicity. The
expression of multi-drug resistant proteins and drug metabo-
lizing enzymes may also play an important role. External
factors that may affect the tumor-specificity include the type
of serum, oxygen concentration, metallic ion presence/con-
centration and external pressure. The cytotoxic activity of
curcumin and nobobactins was significantly inhibited by the
addition of FeCl3 due to the chelate formation. Systematiza-
tion of the relationship between various factors mentioned
above and tumor-specificity may contribute to the quest for
more active compounds.
184 H. SakagamiBoth the resistance of tumor cells to anticancer drugs and
the dose-related toxicity remain the most important pro-
blems in the chemotherapy of clinical OSCC. Researchers
have been seeking a combinative treatment regimen to
improve the effect of chemotherapy. 13-Retinoic acid, inter-
feron-a2a and a-tocopherol synergistically induced apoptosis
in squamous cell carcinoma of the head and neck (SCCHN)
may be a basis of the promising outcomes of the phase III trial
with a combination of these three drugs in patients with
advanced head and neck cancer in the adjuvant settings [62].
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